Home › Targets › IP receptor
IP receptor (1 companies · 8 programs)
Companies with an active program directed at IP receptor.
- YUTREPIA — Pulmonary Arterial Hypertension Approved
- YUTREPIA — Pulmonary Hypertension Associated with Interstitial Lung Disease Approved
- YUTREPIA — Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease Phase 1
- YUTREPIA — Idiopathic Pulmonary Fibrosis Phase 1
- YUTREPIA — Progressive Pulmonary Fibrosis Phase 1
- YUTREPIA — Raynaud's Phenomenon Associated with Systemic Sclerosis Phase 1
- L606 — Pulmonary Arterial Hypertension Phase 3
- L606 — Pulmonary Hypertension Associated with Interstitial Lung Disease Phase 3
